glp-1 agonists oral Dosage of analogues Orforglipron, an Oral Small-Molecule GLP-1

We have noticed a similar upward trend in utilization and spend for GLP-1s across our book of business, with plan drug spend for Wegovy alone increasing over 500% between 2022 and 2023

A month following the procedure, those on tirzepatide had a 54% lower risk of experiencing major cardiovascular events like heart attack than dulaglutide users, the researchers found

P = 0.017) compared to nonfatal myocardial infarction (HR 0.96

and sits on an advisory board for the Office of Health Economics

doi:10.1136/bmj.k872

The ability of GLP-1 medications to address both blood sugar control and weight management makes them a valuable asset for people seeking to improve their metabolic health